Allelic Variants
|
There are no related allelic variants
|
|
Number of involved diseases in the family |
75 |
Number of BLK related diseases |
1 |
All kinase in this family
BLK
Allelic Variants |
Disease Description |
Involved kinases (This family) |
Inhibitor of Involved Kinases |
Search Disease |
n/a | Measles | CDK2, CDK4, FYN, GSK3B, IRAK4, PRKCQ | 55 | Link | n/a | Epstein-Barr virus infection | CDK2, FGR, GSK3B, MAPK10, MAPK9 | 36 | Link | | Prostate cancer | CDK2, CHEK2, FGFR2, GSK3B, MAP2K1 | 36 | Link | n/a | Influenza A | GSK3B, IRAK4, MAP2K1, MAPK10, MAPK9 | 7 | Link | n/a | Shigellosis | ABL1, MAPK10, MAPK9, ROCK2, SRC | 42 | Link | n/a | Tuberculosis | IRAK4, MAPK10, MAPK9, SRC | 42 | Link | n/a | Epithelial cell signaling in Helicobacter pylori infection | MAPK10, MAPK9, MET, SRC | 44 | Link | n/a | Chagas disease | IRAK4, MAPK10, MAPK9 | 4 | Link | n/a | Salmonella infection | MAPK10, MAPK9, ROCK2 | 3 | Link | n/a | Toxoplasmosis | IRAK4, MAPK10, MAPK9 | 4 | Link | n/a | Pertussis | IRAK4, MAPK10, MAPK9 | 4 | Link | n/a | Hepatitis C | GSK3B, MAPK10, MAPK9 | 3 | Link | | Leukemia | ABL1, CDK4, MAP2K1 | 48 | Link | n/a | Herpes simplex infection | CDK2, MAPK10, MAPK9 | 32 | Link | n/a | Pathogenic Escherichia coli infection | ABL1, FYN, ROCK2 | 9 | Link | | Melanoma | CDK4, MAP2K1, MET | 46 | Link | n/a | Basal cell carcinoma | GSK3B, STK36 | 2 | Link | | Gastric cancer | FGFR2, MET | 8 | Link | n/a | Prion diseases | FYN, MAP2K1 | 5 | Link | | LADD syndrome | FGFR2, FGFR3 | 5 | Link | | Crouzon syndrome | FGFR2, FGFR3 | 5 | Link | | Diabetes mellitus | MAPK10, MAPK9 | 2 | Link | n/a | Cervical cancer | CDK4, FGFR3 | 43 | Link | | Lung cancer | CDK2, CDK4 | 48 | Link | n/a | Viral myocarditis | ABL1, FYN | 9 | Link | | Scaphocephaly | FGFR2 | 5 | Link | n/a | Saethre-Chotzen syndrome | FGFR2 | 5 | Link | | Craniofacial-skeletal-dermatologic dysplasia | FGFR2 | 5 | Link | | Jackson-Weiss syndrome | FGFR2 | 5 | Link | | Craniosynostosis | FGFR2 | 5 | Link | | Bent bone dysplasia syndrome | FGFR2 | 5 | Link | | Pfeiffer syndrome | FGFR2 | 5 | Link | n/a | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | FGFR2 | 5 | Link | | Beare-Stevenson cutis gyrata syndrome | FGFR2 | 5 | Link | n/a | Glioma | CDK4 | 40 | Link | n/a | Malignant melanoma | CDK4 | 40 | Link | n/a | Maturity onset diabetes of the young | BLK | 6 | Link | | Li-Fraumeni syndrome | CHEK2 | 1 | Link | | Breast cancer | CHEK2 | 1 | Link | | Apert syndrome | FGFR2 | 5 | Link | n/a | Scaphocephaly and Axenfeld-Rieger anomaly | FGFR2 | 5 | Link | n/a | Spondylometaepiphyseal dysplasia | DDR2 | 3 | Link | | Osteosarcoma | CHEK2 | 1 | Link | | Colorectal cancer | FGFR3 | 3 | Link | n/a | Multiple myeloma | FGFR3 | 3 | Link | | Renal cell carcinoma | MET | 6 | Link | n/a | Cholangiocarcinoma | MET | 6 | Link | n/a | Epileptic encephalopathy | MAPK10 | 2 | Link | n/a | Early infantile epileptic encephalopathy | MAPK10 | 2 | Link | n/a | Alcoholism | MAP2K1 | 3 | Link | | Cardiofaciocutaneous syndrome | MAP2K1 | 3 | Link | n/a | Malaria | MET | 6 | Link | n/a | Autism suseptibility | MET | 6 | Link | n/a | Type I diabetes mellitus | PRKCQ | 1 | Link | | Colon cancer | SRC | 42 | Link | | Glycogen storage disease | PHKG2 | 4 | Link | n/a | Cirrhosis due to liver phosphorylase kinase deficiency | PHKG2 | 4 | Link | | Hepatocellular carcinoma | MET | 6 | Link | n/a | Glycogen storage diseases | PHKG2 | 4 | Link | n/a | Noonan syndrome and related disorders | MAP2K1 | 3 | Link | | SCID | LCK | 9 | Link | n/a | Hypochondroplasia | FGFR3 | 3 | Link | n/a | Muenke syndrome | FGFR3 | 3 | Link | n/a | Achondroplasia | FGFR3 | 3 | Link | n/a | CATSHL syndrome | FGFR3 | 3 | Link | n/a | Bladder cancer | FGFR3 | 3 | Link | n/a | FGFR3-related short limb skeletal dysplasias | FGFR3 | 3 | Link | n/a | Nevus | FGFR3 | 3 | Link | n/a | Spermatocytic seminoma | FGFR3 | 3 | Link | | IRAK4 deficiency | IRAK4 | 3 | Link | n/a | Immunodeficiencies | LCK | 9 | Link | n/a | Invasive pneumococcal disease | IRAK4 | 3 | Link | n/a | Leishmaniasis | IRAK4 | 3 | Link | n/a | Thanatophoric dysplasia | FGFR3 | 3 | Link | n/a | Cancer progression/metastasis | FGFR4 | 1 | Link |
|